BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  ACEA Release: Real-Time Monitoring of Cancer Cells Under Hypoxic Conditions Reveals Novel Regulator of Proliferation and Migration

  A team of Korean scientists headed by Bu Young Choi at Seowon University have described an elegant solution to this challenge by placing an xCELLigence Real-Time Cell Analyzer (RTCA) directly within a hypoxia chamber.

  December 20, 2017

   · 

  3 min read
• Business

  Renovion Elects Derek Winstanly as Chairman of Board of Directors

  Dr. Winstanly served as the Executive Vice President, Chief Customer and Governance Officer of Quintiles Transnational, November 2011- 2015.

  December 20, 2017

   · 

  2 min read
• Pharm Country

  Applied DNA Announces $4.8 Million Registered Direct Offering of Common Stock

  Each share of common stock is being sold together with a warrant to purchase one share of common stock at a combined effective price to the public of $1.75.

  December 20, 2017

   · 

  4 min read
• 

  Genetown

  Flagship Pioneering Secures $618M for Life Science Startup Mission

  The total capital raised by Flagship to fuel its institutional innovation and venture creation platform now exceeds $2.3B.

  December 20, 2017

   · 

  5 min read
• Drug Development

  Achillion Initiates Phase I First-in Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor D

  This initial phase 1 trial is a randomized, placebo-controlled, single-ascending dose study of ACH-5228 administered to healthy volunteers.

  December 20, 2017

   · 

  5 min read
• Biotech Bay

  Aduro Biotech Expands Leading Intellectual Property Position in STING Field with Newly Issued Patent

  The STING pathway plays a central role in the activation of an immune response and in the regulation of inflammation, and therefore, has been implicated in numerous diseases such as cancer and autoimmune disorders.

  December 20, 2017

   · 

  6 min read
• Pharm Country

  Precipio Launches its Second New ICE-COLD PCR Targeted Enrichment Kit to Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies on Sanger Sequencing Platforms

  As part of the transformation of ICP to be platform-agnostic, this kit has been adapted to be used on Sanger Sequencing platforms, a widely used DNA sequencing method in molecular diagnostics.

  December 20, 2017

   · 

  6 min read
• Genetown

  X-Chem Provides Year-End Update on Partnership Achievements

  X-Chem announced that it has licensed its 40th drug discovery program to an undisclosed large Pharma partner, granting exclusive rights to novel small molecules that interact with the partner’s therapeutic target of interest.

  December 20, 2017

   · 

  4 min read
• Drug Development

  Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation by U.S. FDA for Treatment of Lennox-Gastaut Syndrome

  Takeda and Ovid formed a global collaboration in January 2017 to develop and commercialize TAK-935/OV935 for the treatment of developmental and epileptic encephalopathies

  December 20, 2017

   · 

  7 min read
• Business

  BioDelivery Sciences Appoints Scott Plesha to President

  BioDelivery announced the appointment of Scott Plesha, currently Senior VP of Sales and Marketing at BDSI, to the role of President, effective January 2, 2018.

  December 20, 2017

   · 

  4 min read